| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JINF.2006.05.014 |
| P698 | PubMed publication ID | 16876253 |
| P2093 | author name string | Adam P Fraise | |
| P433 | issue | 5 | |
| P304 | page(s) | 293-300 | |
| P577 | publication date | 2006-07-28 | |
| P1433 | published in | Journal of Infection | Q6295344 |
| P1476 | title | Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? | |
| P478 | volume | 53 |
| Q36901960 | Antimicrobial resistance and the management of anaerobic infections. |
| Q37251382 | Development of Tyrocidine A analogues with improved antibacterial activity |
| Q54324569 | High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden. |
| Q37324603 | Novel approaches to discovery of antibacterial agents |
| Q58573884 | Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany |
| Q37270510 | Synthesis and antibacterial activity of doxycycline neoglycosides. |
| Q37058001 | Treatment options for multidrug-resistant Acinetobacter species |
Search more.